- CA$100.63m
- CA$75.66m
- CA$31.59m
- 88
- 48
- 87
- 87
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 21.4 | 22.3 | 28.6 | 27.9 | 31.6 |
Cost of Revenue | |||||
Gross Profit | 16.6 | 17.4 | 22.6 | 22.9 | 25.6 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 16 | 17.3 | 20.4 | 20.9 | 24.1 |
Operating Profit | 5.39 | 5.03 | 8.18 | 6.98 | 7.47 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 5.87 | 5.24 | 8.38 | 7.43 | 8.53 |
Provision for Income Taxes | |||||
Net Income After Taxes | 4.37 | 3.8 | 6.28 | 5.46 | 6.46 |
Net Income Before Extraordinary Items | |||||
Net Income | 4.37 | 3.8 | 6.28 | 5.46 | 6.46 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 4.37 | 3.8 | 6.28 | 5.46 | 6.46 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.36 | 0.29 | 0.488 | 0.441 | 0.531 |
Dividends per Share |